Research

 
 

Upcoming Events

United Drug

Feb 9th

United Drug - interim management statement

United Drug

Feb 9th

United Drug - AGM - Shelbourne Hotel, St. Stephen's Green, Dublin 2 - 12.00

Buzzi Unicem

Feb 9th

Buzzi Unicem - trading statement

Air France KLM

Feb 10th

Air France Q3 results

HeidelbergCement AG

Feb 10th

HeidelbergCement - trading statement

Research

Jump to:  Other Recent Research  |  Regular Products

Highlights

Irish Banks - Countdown to capital raisings
04 Feb 2010 (PDF)
Investors should get greater clarity on the capital requirements and earnings potential of the Irish banks as the key uncertainties around NAMA and the EC's response to restructuring are resolved as early as Q1. Assuming outside capital is forthcoming, we see upside potential of 48% for BKIR and 63% for ALBK. ALBK is higher risk due to its greater capital requirement of €4.1bn (versus €2.2bn for BKIR).
Ryanair Holdings - Yield improvement a positive sign; Q3 results better than expected; costs performance still stellar
01 Feb 2010 (PDF)
Ryanair's net loss of €10.9m for Q3 is better than expected. Full year guidance has been moved up from the lower end of €200-300m to €275m. The key driver for the better numbers and guidance is yields, which were down 12.5% in Q3 and are guided to be down -7-10% in Q4. Cost performance was excellent.
Elan Corp - Basis now exists for stronger Tysabri growth profile; upgrading medium-term forecasts
01 Feb 2010 (PDF)
The 2009 out-turn indicated that the efficacy message can spur growth, even with difficult PML headwinds. Tysabri can approach $2bn in revenues, off a patient base of 73,300, by 2013. This represents a 16% uplift to our previous patient estimates and adds circa $70m to EBITDA in 2013.
Monthly Market Monitor - ISEQ delivers flat performance in January despite early promise
01 Feb 2010 (PDF)
The ISEQ rose just 0.04% in January. This is a poorer-than-average start to the year (the average January performance is 3.0%). Financials fell 0.2% in January, the fourth successive decline for the sector in that month. Industrials rose 0.1%. Small caps performed strongly (+2.5%), while large caps lagged (-0.4%).
Tullow Oil - Pushing the E&P business cycle harder
27 Jan 2010 (PDF)
Tullow's equity raising of £925m will push its appraisal and development assets even harder. It plans to rapidly advance production in Uganda and to repeat the development time-scale achieved on Jubilee with the recent oil discovery at Tweneboa. In addition, up to $500m per annum will be set aside to pursue rank exploration.

Regular Products

Title Date Archive
Weekly Book 08 Feb 2010
08 May 2010 Archive
Monthly Market Monitor 01 Feb 2010 Archive
29 Sep 2009 Archive

Market Movements

Get In Touch

Top 10 Companies
Company Price Change
ARYZTA 27.80 -0.30
Bank of Ireland 1.26 +0.04
CRH 16.90 -0.07
DCC 19.86 -0.04
Dragon Oil 4.85 -0.08
Elan(USc) 6.97 -0.18
Kerry Group 20.45 -0.05
Paddy Power 23.60 0.00
Ryanair 3.42 +0.01
Smurfit Kappa Group 6.37 -0.03
Davy forecast changes
Adj. dil. EPS(c) 2010 2011
February 5th prev rev prev rev
Aer Lingus -8.3 -3.0 -1.7 2.6
Buzzi Unicem 116.6 90.6 151.0 130.9
HeidelbergCement 425.1 460.3 579.8 627.3
CPL Resources 7.1 14.5 14.7 20.7
DCC 178.1 175.1 184.1 179.5
Elan Corp -14.4 -16.8 -9.9 -8.6
Italcementi 51.7 47.3 82.3 70.4
Ryanair Holdings 17.3 20.3 28.7 28.9